Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant...
Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
About this item
Full title
Author / Creator
Publisher
United States: Society of Nuclear Medicine
Journal title
Language
English
Formats
Publication information
Publisher
United States: Society of Nuclear Medicine
Subjects
More information
Scope and Contents
Contents
Glucagon-like peptide-1 (GLP-1) receptor imaging is superior to somatostatin receptor subtype 2 (sst(2)) imaging in localizing benign insulinomas. Here, the role of GLP-1 and sst(2) receptor imaging in the management of malignant insulinoma patients was investigated.
Eleven patients with malignant insulinoma were prospectively included. (111)In-...
Alternative Titles
Full title
Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_910642778
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_910642778
Other Identifiers
ISSN
0161-5505
E-ISSN
2159-662X,1535-5667
DOI
10.2967/jnumed.110.085142
